The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Efficacy of low-dose interferon therapy for treating chronic hepatitis C patients who cannot tolerate standard treatment
Author(s): 
Pages: 20-24
Year: Issue:  1
Journal: Chinese Journal of Hepatology

Keyword:  Hepatitis CchronicInterferonlow doseVirology responses;
Abstract: 目的 针对不能耐受标准治疗方案的慢性丙型肝炎(CHC)患者,探索低剂量干扰素联合利巴韦林长期维持治疗的效果,并分析与疗效相关的可能影响因素. 方法 对于白细胞低下、甲状腺功能异常等多种原因不能耐受标准治疗方案的CHC患者46例,给予个体化低剂量干扰素(标准干扰素60万~300万IU隔日一次,聚乙二醇干扰素50 ~ 90μg/周)联合利巴韦林0.6 ~ 0.9 g/d 长期维持治疗,疗程≥72周...
Related Articles
loading...